Lido Advisors LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 14.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 33,963 shares of the company’s stock after selling 5,697 shares during the quarter. Lido Advisors LLC’s holdings in Cardinal Health were worth $7,557,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of CAH. BlackRock Inc. purchased a new stake in shares of Cardinal Health in the second quarter valued at approximately $6,293,115,000. Wellington Management Group LLP raised its stake in shares of Cardinal Health by 247.5% during the 2nd quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after buying an additional 10,584,119 shares during the period. Bank of America Corp DE purchased a new position in shares of Cardinal Health during the 2nd quarter valued at approximately $689,066,000. Legal & General Group Plc purchased a new position in shares of Cardinal Health during the 2nd quarter valued at approximately $438,870,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Cardinal Health during the 2nd quarter valued at approximately $308,640,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.
Insider Activity at Cardinal Health
In other Cardinal Health news, CAO Mary C. Scherer sold 2,302 shares of Cardinal Health stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $237.39, for a total transaction of $546,471.78. Following the sale, the chief accounting officer owned 2,811 shares of the company’s stock, valued at $667,303.29. The trade was a 45.02% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jason Hollar sold 44,529 shares of the company’s stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $236.18, for a total transaction of $10,516,859.22. Following the sale, the chief executive officer directly owned 190,603 shares of the company’s stock, valued at $45,016,616.54. The trade was a 18.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 210,271 shares of company stock worth $49,626,657 over the last 90 days. Corporate insiders own 0.12% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on CAH
Cardinal Health Price Performance
NYSE CAH opened at $277.97 on Friday. The company has a market cap of $64.25 billion, a PE ratio of 35.96, a price-to-earnings-growth ratio of 2.13 and a beta of 0.53. The stock’s 50 day simple moving average is $243.50 and its 200-day simple moving average is $224.91. Cardinal Health, Inc. has a 1-year low of $180.45 and a 1-year high of $286.29.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.94 by $0.32. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The firm had revenue of $67.51 billion for the quarter, compared to analyst estimates of $66.67 billion. During the same period in the previous year, the company posted $2.55 earnings per share. The business’s revenue was up 5.5% on a year-over-year basis. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 12.96 EPS for the current fiscal year.
Cardinal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be issued a $0.5158 dividend. The ex-dividend date is Monday, January 4th. This represents a $2.06 dividend on an annualized basis and a yield of 0.7%. Cardinal Health’s dividend payout ratio (DPR) is presently 26.65%.
Cardinal Health Profile
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.
Further Reading
- Five stocks we like better than Cardinal Health
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
